Jenburkt Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. L

A side-by-side comparison of Jenburkt Pharmaceuticals Ltd (524731) and APOLLO HOSPITALS ENTER. L (APOLLOHOSP) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Jenburkt Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. L are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation31
  • Profitability31
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

524731 takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

14.30
P/E ratio
64.48
2.33
P/B ratio
12.55
2.01%
Dividend yield
0.22%
₹72.64
EPS
₹135.04

Profitability

524731 takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.20%
Return on equity
21.20%
27.00%
Return on capital
17.00%
27.00%
EBITDA margin
15.00%
21.05%
Net margin
7.94%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

9.32%
Revenue CAGR (3Y)
14.94%
11.55%
Profit CAGR (3Y)
33.39%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹456 Cr
Market cap
₹1.25L Cr
₹152 Cr
Revenue
₹25,228 Cr
₹32 Cr
Net profit
₹2,003 Cr
0.01
Debt / equity
0.32
Jenburkt Pharmaceuticals Ltd
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 9.08% over past five years."]
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Jenburkt Pharmaceuticals Ltd full analysis APOLLO HOSPITALS ENTER. L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.